These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Psychotropic drugs and the risk of arrhythmias]. Toivonen L Duodecim; 2002; 118(12):1223-4. PubMed ID: 12239813 [No Abstract] [Full Text] [Related]
3. [Reduction of prolonged QTc-interval related risks in treatment with neuropharmacological drugs. Recommendations for clinical practice]. van de Kraats GB; Slob J; Tenback DE Tijdschr Psychiatr; 2007; 49(1):43-7. PubMed ID: 17225205 [TBL] [Abstract][Full Text] [Related]
4. [Minimizing the risks associated with QTc prolongation in people with schizophrenia. A consensus statement by the Cardiac Safety in Schizophrenia Group]. Ames D; Camm J; Cook P; Falkai P; Gury C; Hurley R; Johnson G; Piepho R; Vieweg V; Encephale; 2002; 28(6 Pt 1):552-62. PubMed ID: 12506268 [TBL] [Abstract][Full Text] [Related]
5. Long QT syndrome caused by noncardiac drugs. Viskin S; Justo D; Halkin A; Zeltser D Prog Cardiovasc Dis; 2003; 45(5):415-27. PubMed ID: 12704598 [TBL] [Abstract][Full Text] [Related]
6. [Antipsychotic agents and the heart]. Huttunen MO Duodecim; 2002; 118(15):1579. PubMed ID: 12244632 [No Abstract] [Full Text] [Related]
7. Quinidine syncope and the delayed repolarization syndromes. Reynolds EW; Vander Ark CR Mod Concepts Cardiovasc Dis; 1976 Aug; 45(8):117-22. PubMed ID: 790149 [No Abstract] [Full Text] [Related]
8. Drugs, QT interval abnormalities and ventricular arrhythmias. Thomas SH Adverse Drug React Toxicol Rev; 1994; 13(2):77-102. PubMed ID: 7918900 [No Abstract] [Full Text] [Related]
9. Drug-induced Brugada syndrome with ST-T wave alternans and long QT. Roberts-Thomson KC; Teo KS; Young GD Intern Med J; 2007 Mar; 37(3):199-200. PubMed ID: 17316344 [No Abstract] [Full Text] [Related]
10. Drug-induced arrhythmias and sudden cardiac death: implications for the pharmaceutical industry. Killeen MJ Drug Discov Today; 2009 Jun; 14(11-12):589-97. PubMed ID: 19508921 [TBL] [Abstract][Full Text] [Related]
12. QT prolongation and syncope with methadone, doxepin, and a beta-blocker. Rademacher S; Dietz R; Haverkamp W Ann Pharmacother; 2005 Oct; 39(10):1762-3. PubMed ID: 16144878 [No Abstract] [Full Text] [Related]
13. [Severe proarrhythmias in cisapride therapy. Simple precautionary measures reduce the risk]. Darpö B Lakartidningen; 1997 Nov; 94(47):4317-20. PubMed ID: 9424525 [No Abstract] [Full Text] [Related]
15. [Drug-induced arrhythmia a difficult to catch adverse effect. New guidelines for increased cardiovascular safety]. Darpö B Lakartidningen; 2006 Apr 5-11; 103(14):1094-5. PubMed ID: 16681092 [No Abstract] [Full Text] [Related]
16. [Cardiac effects of antipsychotics: mechanism of arrhythmias and sudden cardiac death]. Kecskeméti V Neuropsychopharmacol Hung; 2004 Mar; 6(1):5-12. PubMed ID: 15125308 [TBL] [Abstract][Full Text] [Related]
17. QT prolongation and development of torsades de pointes with the concomitant administration of oral erythromycin base and quinidine. Lin JC; Quasny HA Pharmacotherapy; 1997; 17(3):626-30. PubMed ID: 9165570 [TBL] [Abstract][Full Text] [Related]
18. The long QT syndrome: when syncope is common to the young and the elderly. Futterman LG; Lemberg L Am J Crit Care; 1995 Sep; 4(5):405-12. PubMed ID: 7489046 [No Abstract] [Full Text] [Related]
19. Impact of hospital pharmacist interventions on the combination of citalopram or escitalopram with other QT-prolonging drugs. Chastang A; Renet S; Corny J; Beaussier H; Petre A; Lillo-Lelouet A; Phan Thi TT; Bézie Y Int J Clin Pharm; 2019 Feb; 41(1):42-48. PubMed ID: 30610545 [TBL] [Abstract][Full Text] [Related]
20. [Treatment of quinidine syncope by cardiac pacing]. Gussarasky J; Kristal N; Gueron M Harefuah; 1972 Apr; 82(8):354-6. PubMed ID: 5050684 [No Abstract] [Full Text] [Related] [Next] [New Search]